5-homopyridoxals, 5-thiopyridoxal, and related compounds. Synthesis, tautomerism, and biological properties.
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D003903:Deuterium; D005260:Female; D006836:Hydro-Lyases / Q000037:antagonists & inhibitors; D007259:Infrared Rays; D008099:Liver / Q000201:enzymology; D008221:Lymphoid Tissue / Q000187:drug effects; D009682:Magnetic Resonance Spectroscopy; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D051379:Mice; D009504:Neutrophils / Q000187:drug effects; D010770:Phosphotransferases / Q000037:antagonists & inhibitors; D011736:Pyridoxine / Q000138:chemical synthesis* / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D012440:Saccharomyces / Q000187:drug effects; D012694:Serine; D013057:Spectrum Analysis; D014166:Transferases / Q000037:antagonists & inhibitors; D014444:Tyrosine Transaminase / Q000037:antagonists & inhibitors
D012694:Serine; D003903:Deuterium; D014166:Transferases; D014444:Tyrosine Transaminase; D010770:Phosphotransferases; D006836:Hydro-Lyases; D011736:Pyridoxine